Assisted Reproductive Technology Survey (ART Survey) — ART

Female Reproductive Problem Clinical Trial

Official title:
ART Survey: Assisted Reproductive Technology Survey

Status Completed

Clinical Trial Summary

The purpose of the study is to collate local information to better understand the motivations, accessibility and frequency of assisted reproductive technology (ART) use in the community.

Clinical Trial Description

The ART survey study recruitment will last about 6 months with the study completed within 1 year. Study participation is an online survey which takes approximately 3 minutes to complete. The goal is to apply for future funding to study the metabolic consequences of being conceived with ART. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02249390
Study type	Observational
Source	Pennington Biomedical Research Center
Contact
Status	Completed
Phase
Start date	September 2014
Completion date	April 2017

View Details

See also
Status	Clinical Trial	Phase
Unknown status	`NCT02213627` - Use of Corifolitropin Alfa in Oocyte Donors	Phase 4
Terminated	`NCT02377219` - Bisphenol A Exposure, Ovarian Function and Assisted Reproductive Technology Outcome.	N/A
Recruiting	`NCT02644304` - Clomiphene Citrate Plus Cabergoline in Treatment of Polycystic Ovary Syndrome	Phase 2
Completed	`NCT03617354` - The Implementation of MinimAlly Invasive Hysterectomy Trial